ADVERTISEMENT

Bell-Kenz, DOTr collaborate to boost CPR training and emergency response in transport hubs

Published Feb 2, 2026 11:06 am  |  Updated Feb 2, 2026 01:57 pm

At A Glance

  • Bell-Kenz Pharm, led by Dr. Luis Raymond T. Go, partners with DOTr-SAICT to boost emergency response and CPR training at transport hubs.
  • The two parties discussed integrating Bell-Kenz's Sagip CPR program into the DOTr's road safety campaign, Oplan Biyaheng Ayos.
From left: Christian Emanuelle Bona; Dr. James Cayetano; Dr. Luis Raymond T. Go; Commodore Oliver Sy Tanseco; Mr. Patrick Larraga; Ms. Anna Leah Morales; Richie Manuel; Ms. Brandy Ong; and Ms.Sheilah Pascual Alvero.
From left: Christian Emanuelle Bona; Dr. James Cayetano; Dr. Luis Raymond T. Go; Commodore Oliver Sy Tanseco; Mr. Patrick Larraga; Ms. Anna Leah Morales; Richie Manuel; Ms. Brandy Ong; and Ms.Sheilah Pascual Alvero.
Building on the successful rollout of its national advocacy last year, Bell-Kenz Pharma is strengthening its emergency preparedness campaign across the country’s transport sector through a partnership with the Department of Transportation’s Special Action and Intelligence Committee for Transportation (DOTr-SAICT) to further its cardiopulmonary resuscitation (CPR) training initiatives.
Since the launch of the Sagip CPR program, Bell-Kenz has been traveling nationwide to conduct hands-on CPR and automated external defibrillator (AED) training, reaching local government units, schools, and communities. These sessions aim to equip ordinary Filipinos with the skills to respond quickly during cardiac emergencies, reinforcing the advocacy’s goal of creating a network of life-saving responders across the country.
During a coordination meeting held on January 29 at The Westin Manila, the two parties discussed integrating Bell-Kenz’s Sagip CPR program into the DOTr’s road safety campaign, Oplan Biyaheng Ayos. The initiative forms part of Bell-Kenz’s nationwide advocacy to train one million Filipinos in hands-only CPR and AED use.
Dr. Luis Raymond T. Go, Bell-Kenz Pharma Medical Director.
Dr. Luis Raymond T. Go, Bell-Kenz Pharma Medical Director.
“In Bell-Kenz, we envision what we call a CPR-ready Philippines, and this is already part of our ongoing initiatives,” Bell-Kenz Pharma medical director Dr. Luis Raymond T. Go said in a statement. “We believe in the collaboration. Our company continues to work with agencies, schools, and government offices to push this program forward.”
The initiative targets transport frontliners deployed at major ports, bus terminals, airports, busways, and thoroughfares, locations where commuters are most at risk and where immediate medical response can save lives.
Anna Leah Morales, supervising transportation regulation officer representing the Office of the SAICT under Assistant Secretary Jose F. Lim IV, highlighted the frequency of medical emergencies in transport facilities.
“We encounter approximately two individuals per month showing symptoms of cardiac events on busways, overpasses, and terminals,” Morales said. “Our personnel are often the first to reach passengers in distress. Equipping our teams with CPR certification is no longer just an added skill—it is a fundamental enhancement of our duty to protect.”
The first phase of the program will focus on training the 400-member DOTr-SAICT enforcement team, whose officers are deployed on a 24-hour rotational basis to maintain public safety across transport corridors.
Commodore Oliver Sy Tanseco, Special Action and Intelligence Committee for Transportation Commander (DOTr-SAICT) with Patrick Larraga of Bell-Kenz Pharma.
Commodore Oliver Sy Tanseco, Special Action and Intelligence Committee for Transportation Commander (DOTr-SAICT) with Patrick Larraga of Bell-Kenz Pharma.
According to Patrick Larraga, Bell-Kenz Pharma’s corporate branding and PR head, partnering with the DOTr allows the Sagip CPR program to reach communities where immediate response is most critical.
“The DOTr’s extensive network provides a strong platform for our advocacy,” Larraga said. “By starting with SAICT and Coast Guard personnel and eventually including bus operators and terminal staff, we aizm to integrate life-saving skills directly into everyday travel.”
After the rollout and completion of training in Metro Manila, Bell-Kenz and the DOTr-SAICT plan to expand the program to regional transport hubs nationwide.
About Bell-Kenz Pharma:
Bell-Kenz Pharma is a Filipino-owned pharmaceutical company dedicated to providing
high-quality yet affordable healthcare solutions, including nutritional support like EnPlus Gold 400g (https://tinyurl.com/EnPlus-Gold-400g) to help Filipinos meet their daily health needs.
Its flagship initiative, Sagip CPR, is a nationwide campaign aiming to train 1 million Filipinos in Hands-Only CPR, empowering communities to respond confidently in cardiac emergencies.
For more information, contact Paula San Esteban at [email protected] or visit www.bell-kenz.net
Follow @bellkenzpharma on Facebook, YouTube, and TikTok for the latest updates on their advocacy and initiatives.

Related Tags

Bell-Kenz Department of Transportation (DOTr) Sagip CPR CPR training Dr Luis Raymond T Go
ADVERTISEMENT
.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1561_widget.title }}

.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1562_widget.title }}

.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1563_widget.title }}

{{ articles_filter_1564_widget.title }}

.mb-article-details { position: relative; } .mb-article-details .article-body-preview, .mb-article-details .article-body-summary{ font-size: 17px; line-height: 30px; font-family: "Libre Caslon Text", serif; color: #000; } .mb-article-details .article-body-preview iframe , .mb-article-details .article-body-summary iframe{ width: 100%; margin: auto; } .read-more-background { background: linear-gradient(180deg, color(display-p3 1.000 1.000 1.000 / 0) 13.75%, color(display-p3 1.000 1.000 1.000 / 0.8) 30.79%, color(display-p3 1.000 1.000 1.000) 72.5%); position: absolute; height: 200px; width: 100%; bottom: 0; display: flex; justify-content: center; align-items: center; padding: 0; } .read-more-background a{ color: #000; } .read-more-btn { padding: 17px 45px; font-family: Inter; font-weight: 700; font-size: 18px; line-height: 16px; text-align: center; vertical-align: middle; border: 1px solid black; background-color: white; } .hidden { display: none; }
function initializeAllSwipers() { // Get all hidden inputs with cms_article_id document.querySelectorAll('[id^="cms_article_id_"]').forEach(function (input) { const cmsArticleId = input.value; const articleSelector = '#article-' + cmsArticleId + ' .body_images'; const swiperElement = document.querySelector(articleSelector); if (swiperElement && !swiperElement.classList.contains('swiper-initialized')) { new Swiper(articleSelector, { loop: true, pagination: false, navigation: { nextEl: '#article-' + cmsArticleId + ' .swiper-button-next', prevEl: '#article-' + cmsArticleId + ' .swiper-button-prev', }, }); } }); } setTimeout(initializeAllSwipers, 3000); const intersectionObserver = new IntersectionObserver( (entries) => { entries.forEach((entry) => { if (entry.isIntersecting) { const newUrl = entry.target.getAttribute("data-url"); if (newUrl) { history.pushState(null, null, newUrl); let article = entry.target; // Extract metadata const author = article.querySelector('.author-section').textContent.replace('By', '').trim(); const section = article.querySelector('.section-info ').textContent.replace(' ', ' '); const title = article.querySelector('.article-title h1').textContent; // Parse URL for Chartbeat path format const parsedUrl = new URL(newUrl, window.location.origin); const cleanUrl = parsedUrl.host + parsedUrl.pathname; // Update Chartbeat configuration if (typeof window._sf_async_config !== 'undefined') { window._sf_async_config.path = cleanUrl; window._sf_async_config.sections = section; window._sf_async_config.authors = author; } // Track virtual page view with Chartbeat if (typeof pSUPERFLY !== 'undefined' && typeof pSUPERFLY.virtualPage === 'function') { try { pSUPERFLY.virtualPage({ path: cleanUrl, title: title, sections: section, authors: author }); } catch (error) { console.error('ping error', error); } } // Optional: Update document title if (title && title !== document.title) { document.title = title; } } } }); }, { threshold: 0.1 } ); function showArticleBody(button) { const article = button.closest("article"); const summary = article.querySelector(".article-body-summary"); const body = article.querySelector(".article-body-preview"); const readMoreSection = article.querySelector(".read-more-background"); // Hide summary and read-more section summary.style.display = "none"; readMoreSection.style.display = "none"; // Show the full article body body.classList.remove("hidden"); } document.addEventListener("DOMContentLoaded", () => { let loadCount = 0; // Track how many times articles are loaded const offset = [1, 2, 3, 4, 5, 6, 7, 8, 9, 10]; // Offset values const currentUrl = window.location.pathname.substring(1); let isLoading = false; // Prevent multiple calls if (!currentUrl) { console.log("Current URL is invalid."); return; } const sentinel = document.getElementById("load-more-sentinel"); if (!sentinel) { console.log("Sentinel element not found."); return; } function isSentinelVisible() { const rect = sentinel.getBoundingClientRect(); return ( rect.top < window.innerHeight && rect.bottom >= 0 ); } function onScroll() { if (isLoading) return; if (isSentinelVisible()) { if (loadCount >= offset.length) { console.log("Maximum load attempts reached."); window.removeEventListener("scroll", onScroll); return; } isLoading = true; const currentOffset = offset[loadCount]; window.loadMoreItems().then(() => { let article = document.querySelector('#widget_1690 > div:nth-last-of-type(2) article'); intersectionObserver.observe(article) loadCount++; }).catch(error => { console.error("Error loading more items:", error); }).finally(() => { isLoading = false; }); } } window.addEventListener("scroll", onScroll); });

Sign up by email to receive news.